Towards a feature-based regulatory benchmark for user-centred SaMD design in cancer care.
PMID: 42173550 ·
S, a, b, a, , K, h, e, i, r, i, n, e, j, a, d, ;, , C, h, r, i, s, t, o, p, h, e, r, , L, , B, r, e, t, t, ;, , R, o, b, e, r, t, , L, , D, a, v, i, s, ;, , D, a, v, i, d, , L, , S, c, h, w, a, r, t, z, ;, , A, r, a, s, h, , S, h, a, b, a, n, -, N, e, j, a, d
Publicidad
Resumen
Software as a medical device (SaMD) is increasingly central to cancer care, yet current regulatory frameworks from the International Medical Device Regulators, the US Food and Drug Administration and the European Medical Device Regulation lack clear premarket standards for evaluating usability, accessibility and emotional/cultural appropriateness for intended users. This gap is particularly problematic in oncology, where patients, caregivers and clinicians navigate high cognitive load, emotional
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.